Most Popular
-
1
40 flights canceled on Jeju Island due to bad weather
-
2
Pandemic left Korea more depressed than before: report
-
3
N. Korea slams US, other countries for seeking alternative to UN sanctions monitoring panel
-
4
Korean labor force to shrink by 10 million by 2044: report
-
5
[AtoZ Korean Mind] Does your job define who you are? Should it?
![[AtoZ Korean Mind] Does your job define who you are? Should it?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/06/20240506050099_0.jpg&u=)
![[AtoZ Korean Mind] Does your job define who you are? Should it?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/06/20240506050099_0.jpg&u=)
-
6
Gov't appears to shelve punitive measures against mass walkout by doctors
-
7
Govt. asks hospitals to mitigate impact of medical professors' absence
-
8
Allegations surrounding BTS resurface, enraged fans demand apology
-
9
S. Korea's working-age population to dip nearly 10m by 2044 amid low births
-
10
Doggy patrol team on the move to protect their cities
KT&G Corp., Korea’s largest tobacco and ginseng product manufacturer, said Wednesday that it will jump into the pharmaceutical business in a bid to diversify its business portfolio.
The company said it launched KT&G Life Sciences Corp., formerly known as Mazence Inc., which KT&G acquired late last year to spearhead the business.
KT&G said it will focus on developing treatments for cancer and osteoporosis and drugs for atopic diseases, as well as new medicines for diabetes and obesity that Mazence has researched.
KT&G Life Sciences will create synergy in cooperation with another affiliate, Yungjin Pharm Industry Co., said KT&G.
“With the launch of KT&G Life Sciences, we can build a balanced business portfolio of tobacco, health care products, cosmetics, and bio and pharmaceuticals,” said a company official.
KT&G is recently seeking to expand its business territory in efforts to diversify its revenue sources. It took over Somang Cosmetics Co. last year to enter the booming beauty industry.
(Yonhap News)
The company said it launched KT&G Life Sciences Corp., formerly known as Mazence Inc., which KT&G acquired late last year to spearhead the business.
KT&G said it will focus on developing treatments for cancer and osteoporosis and drugs for atopic diseases, as well as new medicines for diabetes and obesity that Mazence has researched.
KT&G Life Sciences will create synergy in cooperation with another affiliate, Yungjin Pharm Industry Co., said KT&G.
“With the launch of KT&G Life Sciences, we can build a balanced business portfolio of tobacco, health care products, cosmetics, and bio and pharmaceuticals,” said a company official.
KT&G is recently seeking to expand its business territory in efforts to diversify its revenue sources. It took over Somang Cosmetics Co. last year to enter the booming beauty industry.
(Yonhap News)
-
Articles by Korea Herald
